UBS maintains IBM stock Sell rating, $170 price target

Published 07/05/2025, 17:06
© Reuters.

On Wednesday, UBS reiterated its Sell rating on IBM (NYSE:IBM) stock, maintaining a price target of $170.00, notably at the lower end of the current analyst range of $170-$300. According to InvestingPro data, IBM trades near its 52-week high of $266.45, with the stock delivering an impressive 52.93% return over the past year. The reaffirmation comes after the firm’s analysts attended IBM Think 2025, the company’s third annual event showcasing its AI strategy and product developments. The event highlighted IBM’s focus on integrating AI across enterprise operations, a concept IBM refers to as "ushering in the agentic enterprise." This year’s event built on the previous year’s emphasis on providing tools for developing AI applications, moving towards a more holistic incorporation of AI with the introduction of Watson Orchestrate’s agent capabilities.

IBM’s CEO linked the AI advancements presented at Think 2025 to the company’s broader strategy. The focus on hybrid environments as the operational setting, AI as the key to unlocking productivity, and Quantum computing as the horizon of technological innovation was underscored. With annual revenue of $62.83 billion and a market capitalization of $228.1 billion, IBM maintains its position as a prominent player in the IT Services industry. Despite these developments and the company’s GOOD Financial Health Score from InvestingPro, UBS’s stance on IBM stock remains unchanged following the event.

At Think 2025, IBM unveiled Watson Orchestrate’s comprehensive set of agent capabilities, which include pre-built agents, tools for developing new agents, integration and coordination of agents, and providing observability into their functions. These advancements are aimed at driving productivity improvements and enhancing end-user experiences across enterprises.

IBM’s extended management team and Product Managers responsible for AI-centric offerings were present at the event, providing insights into the company’s direction and initiatives. The demonstrations offered a glimpse into how IBM’s products are designed to enhance efficiency and productivity in the enterprise space.

The UBS analyst’s commentary after attending the event indicates that while IBM is deeply invested in AI and has made significant strides in the field, the firm’s valuation of IBM stock remains cautious with a Sell rating and a price target that reflects their assessment. Trading at a P/E ratio of 42.03, IBM has demonstrated its commitment to shareholder returns with 29 consecutive years of dividend increases. For deeper insights into IBM’s valuation and growth prospects, InvestingPro subscribers can access the comprehensive Pro Research Report, offering expert analysis of key metrics and future potential.

In other recent news, IBM has been involved in several notable developments. IBM announced a partnership with Lumen Technologies to enhance AI solutions for real-time data processing at the edge of networks. This collaboration aims to improve AI deployment in sectors like healthcare and retail by integrating IBM’s Watson AI with Lumen’s Edge Cloud infrastructure. Additionally, IBM is collaborating with Oracle (NYSE:ORCL) to integrate its AI portfolio, watsonx, with Oracle Cloud Infrastructure, focusing on deploying AI across business operations. This partnership will initially target human resources applications and is expected to enhance enterprise productivity.

IBM is also in the running for a significant contract to modernize the U.S. air traffic control system, as mentioned by President Donald Trump. IBM and Raytheon Technologies (NYSE:RTX) are among the potential candidates for this project, which aims to replace outdated technology with a more efficient and safer system. In terms of financial analysis, both Morgan Stanley (NYSE:MS) and BMO Capital Markets have maintained their ratings on IBM stock, with Morgan Stanley setting a price target of $233 and BMO Capital Markets at $260. Morgan Stanley’s analysis highlights IBM’s strategic positioning in the GenAI sector, while BMO Capital Markets sees potential in IBM’s software growth.

These developments reflect IBM’s ongoing efforts to expand its technological capabilities and strategic partnerships. The company’s focus on AI and cloud solutions, alongside its potential role in the air traffic control system overhaul, underscores its commitment to innovation in high-value sectors.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.